---
layout: post
title: 新冠疫苗价格浮现：中国产疫苗高定价Vs 美国政府全球大采购
date: 2020-09-25 10:45:49.000000000 +08:00
categories: bbc
---

<main role="main"><div class="GridItemConstrainedLarge-sc-12lwanc-4 gVouae"></div><div class="GridItemConstrainedMedium-sc-12lwanc-2 fVauYi StyledTimestamp-uounnc-1 ebSCEt"><time dateTime="2020-09-25" class="StyledTimestamp-um718p-0 iENDai">25 分钟前</time></div><div class="GridItemConstrainedLargeNoMargin-sc-12lwanc-5 tOkbK"><div class="Figure-sc-6a3dhy-0 gJUCFc"><div class="NestedGridParentLarge-sc-12lwanc-10 hfLVVX"><div class="NestedGridItemChildLarge-sc-12lwanc-9 fkKpIa"><div class="ImagePlaceholder-sc-11u25v2-0 _StyledImagePlaceholder-gu1fm2-0 kvTWeV"><img srcSet="https://ichef.bbci.co.uk/news/240/cpsprodpb/13658/production/_114584497_063455394.jpg 240w, https://ichef.bbci.co.uk/news/320/cpsprodpb/13658/production/_114584497_063455394.jpg 320w, https://ichef.bbci.co.uk/news/480/cpsprodpb/13658/production/_114584497_063455394.jpg 480w, https://ichef.bbci.co.uk/news/624/cpsprodpb/13658/production/_114584497_063455394.jpg 624w, https://ichef.bbci.co.uk/news/800/cpsprodpb/13658/production/_114584497_063455394.jpg 800w" alt="A small bottle labeled with a &quot;Vaccine&quot; sticker is held near a medical syringe in front of displayed &quot;Coronavirus COVID-19&quot; words in this illustration taken April 10, 2020" src="https://images.weserv.nl/?url=ichef.bbci.co.uk/news/640/cpsprodpb/13658/production/_114584497_063455394.jpg" width="976" class="StyledImg-sc-7vx2mr-0 dQLeqZ"/><p role="text" class="Copyright-sc-11lgtw-0 hDvIfz"><span class="VisuallyHiddenText-sc-1yjwwa5-0 ldFJPH">图像来源，</span><span lang="en-GB">Reuters</span></p></div></div><div class="NestedGridItemChildLarge-sc-12lwanc-9 ichKJL"></div></div></div></div><div class="GridItemConstrainedMedium-sc-12lwanc-2 fVauYi"><p class="Paragraph-k859h4-0 bWtIRA"><b>随着全球多款疫苗的初步定价浮出水面，中美两国的疫苗定价和民众可负担程度比较成为互联网上热议的话题。全球单剂疫苗的已知定价范围从20元人民币（3美元）到300人民币（44美元）不等。目前的市场吹风价格中，单支最贵的疫苗出自中国国药集团。</b></p></div><div class="GridItemConstrainedMedium-sc-12lwanc-2 fVauYi"><p class="Paragraph-k859h4-0 bWtIRA">中国目前有三款已经在进行临床三期的疫苗，一款由中国军方和康希诺生物公司研发；另一款是由中国国药集团和中国疾控病毒所研发的灭活疫苗，最后一款则由中国医科院和科兴中维生物共同研发的灭活疫苗。</p></div><div class="GridItemConstrainedMedium-sc-12lwanc-2 fVauYi"><p class="Paragraph-k859h4-0 bWtIRA">除了本土研发外，美国政府亦在全球订购疫苗，并以“政府协议价”锁定疫苗采购，以期供部分民众免费接种。中国目前没有从国外订购疫苗的公开信息，也不知道中国自产疫苗是否让本国民众大规模免费接种。</p></div><div class="GridItemConstrainedLargeNoMargin-sc-12lwanc-5 tOkbK"><div class="Figure-sc-6a3dhy-0 gJUCFc"><div class="NestedGridParentLarge-sc-12lwanc-10 hfLVVX"><div class="NestedGridItemChildLarge-sc-12lwanc-9 fkKpIa"><div class="ImagePlaceholder-sc-11u25v2-0 _StyledImagePlaceholder-gu1fm2-0 kvTWeV"><div class="lazyload-wrapper"><div class="lazyload-placeholder"></div></div><img alt="A specialist works at Binnopharm pharmaceutical plant, part of Alium Group owned by Sistema financial corporation, which develops &quot;Gam-COVID-Vac&quot; vaccine against the coronavirus disease (COVID-19) in Zelenograd near Moscow, Russia September 18, 2020" src="https://images.weserv.nl/?url=ichef.bbci.co.uk/news/640/cpsprodpb/18478/production/_114584499_mediaitem114584498.jpg" width="976" class="StyledImg-sc-7vx2mr-0 dQLeqZ"/><p role="text" class="Copyright-sc-11lgtw-0 hDvIfz"><span class="VisuallyHiddenText-sc-1yjwwa5-0 ldFJPH">图像来源，</span><span lang="en-GB">Reuters</span></p></div></div><div class="NestedGridItemChildLarge-sc-12lwanc-9 ichKJL"></div></div></div></div><div class="GridItemConstrainedMedium-sc-12lwanc-2 fVauYi"><p class="Paragraph-k859h4-0 bWtIRA">在这场全球重大公共危机中，疫苗定价该按市场供需矛盾让生产商获利还是按成本定价？政府是否该让全员免费接种，费用由政府买单？</p></div><section aria-label="广告 2" aria-hidden="true" role="region" data-e2e="advertisement" class="AdContainer-sc-8mk8fx-0 itFDSt MpuContainer-uounnc-0 koWnML"><div id="dotcom-mpu" class="dotcom-ad"></div></section><div class="GridItemConstrainedMedium-sc-12lwanc-2 fVauYi"><p class="Paragraph-k859h4-0 bWtIRA">目前很难一概而论。但在全球重大公共危机面前，企业显然面临定价压力。</p></div><div class="GridItemConstrainedMedium-sc-12lwanc-2 fVauYi"><div class="Wrapper-e2169q-0 kopXQT"><ul dir="ltr" role="list" class="BulletedList-sc-13z0d8v-0 biIiLh"><li role="listitem" class="BulletedListItem-sc-13z0d8v-1 kHsWph"><a href="https://www.bbc.com/zhongwen/simp/world-54042207" class="InlineLink-hkwpaz-0 idscKS">新冠疫苗：俄罗斯报告称疫苗出现免疫反应迹象</a></li><li role="listitem" class="BulletedListItem-sc-13z0d8v-1 kHsWph"><a href="https://www.bbc.com/zhongwen/simp/science-52545310" class="InlineLink-hkwpaz-0 idscKS">全球新冠病毒疫苗研发竞赛 中美英六款领跑</a></li><li role="listitem" class="BulletedListItem-sc-13z0d8v-1 kHsWph"><a href="https://www.bbc.com/zhongwen/simp/world-52447730" class="InlineLink-hkwpaz-0 idscKS">印度为什么在研治新冠疫苗中如此重要</a></li><li role="listitem" class="BulletedListItem-sc-13z0d8v-1 kHsWph"><a href="https://www.bbc.com/zhongwen/simp/science-52335730" class="InlineLink-hkwpaz-0 idscKS">全球研发百花齐放  人类离首支新冠疫苗还有多远</a></li><li role="listitem" class="BulletedListItem-sc-13z0d8v-1 kHsWph"><a href="https://www.bbc.com/zhongwen/simp/science-53749119" class="InlineLink-hkwpaz-0 idscKS">普京批准俄罗斯新冠病毒疫苗投入使用</a></li></ul></div></div><div class="GridItemConstrainedMedium-sc-12lwanc-2 fVauYi"><h2 id="中国疫苗定价再次试探民众反应" tabindex="-1" class="SubHeading-sc-1kh1qhu-1 iZDonF">中国疫苗定价再次试探民众反应</h2></div><div class="GridItemConstrainedMedium-sc-12lwanc-2 fVauYi"><p class="Paragraph-k859h4-0 bWtIRA">据香港《南华早报》报道，中国国药集团的两款灭活疫苗正在申请中国药监部门的有条件批准，一旦获得批准，疫苗可能的最高定价为600元（88美元）。目前这两款灭活疫苗，都需要接种两针，单针价格为300元（44美元）。</p></div><div class="GridItemConstrainedMedium-sc-12lwanc-2 fVauYi"><p class="Paragraph-k859h4-0 bWtIRA">中国国药集团的一款灭活疫苗此前已紧急提供给一些中国国企的出国人员及高危人群自愿使用，据称目前已经接种数十万人次。中国国药集团称无一例明显不良反应，无一人感染。</p></div><div class="GridItemConstrainedLargeNoMargin-sc-12lwanc-5 tOkbK"><div class="Figure-sc-6a3dhy-0 gJUCFc"><div class="NestedGridParentLarge-sc-12lwanc-10 hfLVVX"><div class="NestedGridItemChildLarge-sc-12lwanc-9 fkKpIa"><div class="ImagePlaceholder-sc-11u25v2-0 _StyledImagePlaceholder-gu1fm2-0 kvTWeV"><div class="lazyload-wrapper"><div class="lazyload-placeholder"></div></div><img alt="A booth displaying a coronavirus vaccine candidate from China National Biotec Group (CNBG), a unit of state-owned pharmaceutical giant China National Pharmaceutical Group (Sinopharm), is seen at the 2020 China International Fair for Trade in Services (CIFTIS), following the COVID-19 outbreak, in Beijing, China September 4, 2020." src="https://images.weserv.nl/?url=ichef.bbci.co.uk/news/640/cpsprodpb/50A8/production/_114584602_mediaitem114584601.jpg" width="976" class="StyledImg-sc-7vx2mr-0 dQLeqZ"/><p role="text" class="Copyright-sc-11lgtw-0 hDvIfz"><span class="VisuallyHiddenText-sc-1yjwwa5-0 ldFJPH">图像来源，</span><span lang="en-GB">Reuters</span></p></div></div><div class="NestedGridItemChildLarge-sc-12lwanc-9 ichKJL"><p>中国国药集团曾经透露其生产的疫苗价格可能在1000元人民币以内。</p></div></div></div></div><div class="GridItemConstrainedMedium-sc-12lwanc-2 fVauYi"><p class="Paragraph-k859h4-0 bWtIRA">两针600元的价格目前没有得到生产方的正式确认。但中国国药集团的负责人曾表示，在正式上市以前，这个产品尚无定价，但会充分考虑其可及性、安全性、有效性和人们的支付能力来确定其价格。</p></div><div class="GridItemConstrainedMedium-sc-12lwanc-2 fVauYi"><p class="Paragraph-k859h4-0 bWtIRA">中国网友称价格还是太贵，有网友质问：“与国外疫苗相比，为何中国的定价更贵？”</p></div><div class="GridItemConstrainedMedium-sc-12lwanc-2 fVauYi"><p class="Paragraph-k859h4-0 bWtIRA">另一位微博网友“<a href="https://weibo.com/TZ7788" aria-label="恺投, 外部链接" class="InlineLink-hkwpaz-0 idscKS">恺投</a>”称：不说国内，咱的疫苗优先提供给东南亚国家，他们会买吗？那里的老百姓打得起吗？</p></div><div class="GridItemConstrainedMedium-sc-12lwanc-2 fVauYi"><p class="Paragraph-k859h4-0 bWtIRA">此前中国曾承诺一旦中国疫苗研制成功，将优先供于湄公河区域国家。目前尚未知外输的疫苗定价是否与中国国内价格有别。</p></div><div class="GridItemConstrainedMedium-sc-12lwanc-2 fVauYi"><p class="Paragraph-k859h4-0 bWtIRA">目前9月最新的吹风价符合此前中国国药集团的说法。但上月该集团初次试探市场和民众反应的定价招来不少批评和质疑。</p></div><div class="GridItemConstrainedMedium-sc-12lwanc-2 fVauYi"><p class="Paragraph-k859h4-0 bWtIRA">这已经是中国产疫苗价格引发的第二轮讨论。此前中国国药集团董事长董事长刘敬桢8月18日对中国媒体表示，国药集团的疫苗将于年底12月上市，年产量将达2亿剂。刘敬桢当时表示，两针价格在1000人民币以内， 他解释称，打一针疫苗的保护率大概是97%，两周后可以达到抵抗新冠病毒的水平；如果打两针疫苗，保护率能达到100%。</p></div><div class="GridItemConstrainedLargeNoMargin-sc-12lwanc-5 tOkbK"><div class="Figure-sc-6a3dhy-0 gJUCFc"><div class="NestedGridParentLarge-sc-12lwanc-10 hfLVVX"><div class="NestedGridItemChildLarge-sc-12lwanc-9 fkKpIa"><div class="ImagePlaceholder-sc-11u25v2-0 _StyledImagePlaceholder-gu1fm2-0 kvTWeV"><div class="lazyload-wrapper"><div class="lazyload-placeholder"></div></div><img alt="A booth displaying a coronavirus vaccine candidate from Sinovac Biotech Ltd is seen at the 2020 China International Fair for Trade in Services (CIFTIS), following the COVID-19 outbreak, in Beijing, China September 4, 2020." src="https://images.weserv.nl/?url=ichef.bbci.co.uk/news/640/cpsprodpb/15DCC/production/_114584598_mediaitem114584597.jpg" width="976" class="StyledImg-sc-7vx2mr-0 dQLeqZ"/><p role="text" class="Copyright-sc-11lgtw-0 hDvIfz"><span class="VisuallyHiddenText-sc-1yjwwa5-0 ldFJPH">图像来源，</span><span lang="en-GB">Reuters</span></p></div></div><div class="NestedGridItemChildLarge-sc-12lwanc-9 ichKJL"></div></div></div></div><div class="GridItemConstrainedMedium-sc-12lwanc-2 fVauYi"><p class="Paragraph-k859h4-0 bWtIRA">在中文社交媒体上，“两针1000元以内”被广泛解读为其价格为900多元人民币。</p></div><div class="GridItemConstrainedMedium-sc-12lwanc-2 fVauYi"><p class="Paragraph-k859h4-0 bWtIRA">这是中国疫苗价格的首次吹风，也迅速引来争议。网友批评定价太贵，普通人无法负担。刘敬桢当时表示：“我国14亿人不是人人都有必要打，比如居住在人口密集城市的学生、上班族等是有必要的，而居住在人口稀少的农村地区的人们就可以不用打。”</p></div><div class="GridItemConstrainedMedium-sc-12lwanc-2 fVauYi"><p class="Paragraph-k859h4-0 bWtIRA">微博用户“<a href="https://weibo.com/1987328655" aria-label="薇薇的自留地, 外部链接" class="InlineLink-hkwpaz-0 idscKS">薇薇的自留地</a>”批评说：“董事长亲自忽悠”。另一位网友评论称：“（中国人口）这么大体量，人均收入只有美国六分之一，疫苗则比美国价格还贵，有大药厂预测疫苗价格大约几十美元一针，已经有多国政府说政府买单，注射免费，我们做不到全国免费，起码也应该非常便宜才对。”</p></div><div class="GridItemConstrainedMedium-sc-12lwanc-2 fVauYi"><p class="Paragraph-k859h4-0 bWtIRA">4天后，8月22日，中国国家卫健委科技发展中心主任郑忠伟接受中国官媒央视采访时表示，新冠疫苗属于公共卫生产品，其定价不能以市场的供需矛盾作为定价依据，只能以成本作为定价依据。</p></div><div class="GridItemConstrainedMedium-sc-12lwanc-2 fVauYi"><p class="Paragraph-k859h4-0 bWtIRA">目前尚不清楚中国国药集团的疫苗成本多少，以及中国财政的投入比例。也不清楚中国其它自产疫苗疫苗的定价，而中国军方牵头的疫苗也未知是否供向市场。</p></div><div class="GridItemConstrainedMedium-sc-12lwanc-2 fVauYi"><p class="Paragraph-k859h4-0 bWtIRA">中国官方尚未表态，疫苗接种是否由政府买单。如果由接种者自己买单，中国国药集团的初步定价属全球最贵。</p></div><div class="GridItemConstrainedMedium-sc-12lwanc-2 fVauYi"><div class="Wrapper-e2169q-0 kopXQT"><ul dir="ltr" role="list" class="BulletedList-sc-13z0d8v-0 biIiLh"><li role="listitem" class="BulletedListItem-sc-13z0d8v-1 kHsWph"><a href="http://https://www.bbc.com/zhongwen/simp/world-52379191" class="InlineLink-hkwpaz-0 idscKS">牛津大学流行病学教授陈铮鸣专访：群体免疫有误读，人类必须面对“与病共舞”</a></li><li role="listitem" class="BulletedListItem-sc-13z0d8v-1 kHsWph"><a href="http://https://www.bbc.com/zhongwen/simp/science-53917575" class="InlineLink-hkwpaz-0 idscKS">新冠疫苗研发冲刺上市 你关心的几个问题</a></li><li role="listitem" class="BulletedListItem-sc-13z0d8v-1 kHsWph"><a href="http://https://www.bbc.com/zhongwen/simp/science-53887791" class="InlineLink-hkwpaz-0 idscKS">新冠疫情：疫苗研发竞赛中的抄近路、耍阴招和民族主义</a></li></ul></div></div><div class="GridItemConstrainedMedium-sc-12lwanc-2 fVauYi"><h2 id="美国政府的大规模采购价" tabindex="-1" class="SubHeading-sc-1kh1qhu-1 iZDonF">美国政府的大规模采购价</h2></div><div class="GridItemConstrainedMedium-sc-12lwanc-2 fVauYi"><p class="Paragraph-k859h4-0 bWtIRA">中国国药集团的疫苗价格风声受到民众的关注，其中一个关键点是和欧美疫苗价格的比较。</p></div><div class="GridItemConstrainedMedium-sc-12lwanc-2 fVauYi"><p class="Paragraph-k859h4-0 bWtIRA">在中国之外的全球市场，多款疫苗的定价浮出水面。其中最便宜的是由牛津大学和阿斯利康公司（AstraZeneca）研发的候选疫苗。这款疫苗出售给美国政府时，每剂疫苗的成本价约为4美元。这属于阿斯利康与美国政府的协议价。</p></div><div class="GridItemConstrainedLargeNoMargin-sc-12lwanc-5 tOkbK"><div class="Figure-sc-6a3dhy-0 gJUCFc"><div class="NestedGridParentLarge-sc-12lwanc-10 hfLVVX"><div class="NestedGridItemChildLarge-sc-12lwanc-9 fkKpIa"><div class="ImagePlaceholder-sc-11u25v2-0 _StyledImagePlaceholder-gu1fm2-0 kvTWeV"><div class="lazyload-wrapper"><div class="lazyload-placeholder"></div></div><img alt="特朗普视察一家研发新冠疫苗的实验室。" src="https://images.weserv.nl/?url=ichef.bbci.co.uk/news/640/cpsprodpb/5044/production/_114584502_whatsubject.jpg" width="976" class="StyledImg-sc-7vx2mr-0 dQLeqZ"/><p role="text" class="Copyright-sc-11lgtw-0 hDvIfz"><span class="VisuallyHiddenText-sc-1yjwwa5-0 ldFJPH">图像来源，</span><span lang="en-GB">Getty Images</span></p></div></div><div class="NestedGridItemChildLarge-sc-12lwanc-9 ichKJL"><p>美国总统特朗普视察一家研发新冠疫苗的实验室。</p></div></div></div></div><div class="GridItemConstrainedMedium-sc-12lwanc-2 fVauYi"><p class="Paragraph-k859h4-0 bWtIRA">今年5月，阿斯利康与牛津大学合作研究的疫苗项目获得美国政府12亿美元的前期资金，研发成功后，将向美国提供3亿剂疫苗。</p></div><div class="GridItemConstrainedMedium-sc-12lwanc-2 fVauYi"><p class="Paragraph-k859h4-0 bWtIRA">阿斯利康还表示，不会从本次大流行中获利。路透社援引阿斯利康称，将会以几美金的单剂价格大规模量产新冠疫苗。在拉美的定价不会超过4美元一剂，在印度的单剂价格会定于3美元左右。意大利卫生部门称，这款疫苗在欧洲不会超过2.8美元一剂。</p></div><div class="GridItemConstrainedMedium-sc-12lwanc-2 fVauYi"><p class="Paragraph-k859h4-0 bWtIRA">美国公司强生（Johnson &amp; Johnson）将以每剂约10美元出售。但这个价格也是“政府协议价”，强生公司需向美国政府提供1亿剂疫苗。</p></div><div class="GridItemConstrainedLargeNoMargin-sc-12lwanc-5 tOkbK"><div class="Figure-sc-6a3dhy-0 gJUCFc"><div class="NestedGridParentLarge-sc-12lwanc-10 hfLVVX"><div class="NestedGridItemChildLarge-sc-12lwanc-9 fkKpIa"><div class="ImagePlaceholder-sc-11u25v2-0 _StyledImagePlaceholder-gu1fm2-0 kvTWeV"><div class="lazyload-wrapper"><div class="lazyload-placeholder"></div></div><img alt="A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against the coronavirus disease (COVID-19), in Cambridge, Massachusetts, U.S., May 18, 2020" src="https://images.weserv.nl/?url=ichef.bbci.co.uk/news/640/cpsprodpb/4D1A/production/_114583791_mediaitem114583788.jpg" width="976" class="StyledImg-sc-7vx2mr-0 dQLeqZ"/><p role="text" class="Copyright-sc-11lgtw-0 hDvIfz"><span class="VisuallyHiddenText-sc-1yjwwa5-0 ldFJPH">图像来源，</span><span lang="en-GB">Reuters</span></p></div></div><div class="NestedGridItemChildLarge-sc-12lwanc-9 ichKJL"><p>莫德纳（Moderna）的疫苗报价则相对较高，每剂价格在32至37美金之间。</p></div></div></div></div><div class="GridItemConstrainedMedium-sc-12lwanc-2 fVauYi"><p class="Paragraph-k859h4-0 bWtIRA">美国生物技术公司莫德纳（Moderna）的疫苗报价则相对较高，每剂价格在32至37美金之间。莫德纳说，价格高是因为产量小。</p></div><div class="GridItemConstrainedMedium-sc-12lwanc-2 fVauYi"><p class="Paragraph-k859h4-0 bWtIRA">与美国政府同样有协议价的美国辉瑞公司（Pfizer）和德国制药公司BioNTech共同研发的疫苗，将以20亿美金的价格提供1亿剂候选疫苗给美国政府，即每剂约20美金。每人需接种2剂。</p></div><div class="GridItemConstrainedMedium-sc-12lwanc-2 fVauYi"><h2 id="牟利与否" tabindex="-1" class="SubHeading-sc-1kh1qhu-1 iZDonF">牟利与否</h2></div><div class="GridItemConstrainedMedium-sc-12lwanc-2 fVauYi"><p class="Paragraph-k859h4-0 bWtIRA">不少制药公司受到外界压力，不得不降低定价，避免被指在全球重大公共危机中发大财。</p></div><div class="GridItemConstrainedMedium-sc-12lwanc-2 fVauYi"><p class="Paragraph-k859h4-0 bWtIRA">美国卫生及公共服务部(HHS)表示，美国民众将免费接种，而且不收取接种费。</p></div><div class="GridItemConstrainedLargeNoMargin-sc-12lwanc-5 tOkbK"><div class="Figure-sc-6a3dhy-0 gJUCFc"><div class="NestedGridParentLarge-sc-12lwanc-10 hfLVVX"><div class="NestedGridItemChildLarge-sc-12lwanc-9 fkKpIa"><div class="ImagePlaceholder-sc-11u25v2-0 _StyledImagePlaceholder-gu1fm2-0 kvTWeV"><div class="lazyload-wrapper"><div class="lazyload-placeholder"></div></div><img alt="。" src="https://images.weserv.nl/?url=ichef.bbci.co.uk/news/640/cpsprodpb/EC84/production/_114584506_russianscientistandvaccineviarussiandirectinvestmentfund.jpg" width="976" class="StyledImg-sc-7vx2mr-0 dQLeqZ"/><p role="text" class="Copyright-sc-11lgtw-0 hDvIfz"><span class="VisuallyHiddenText-sc-1yjwwa5-0 ldFJPH">图像来源，</span><span lang="en-GB">Russian Direct Investment Fund</span></p></div></div><div class="NestedGridItemChildLarge-sc-12lwanc-9 ichKJL"></div></div></div></div><div class="GridItemConstrainedMedium-sc-12lwanc-2 fVauYi"><p class="Paragraph-k859h4-0 bWtIRA">专注投资医疗保健板块的投行SVB Leerink分析师波尔吉斯（Geoffrey Porges）认为，以每人40美金计算，疫苗定价“生产商肯定有利润”，而且在某些地区，毛利润在60%到80%左右。</p></div><div class="GridItemConstrainedMedium-sc-12lwanc-2 fVauYi"><p class="Paragraph-k859h4-0 bWtIRA">波尔吉斯说，这项交易“将为新冠疫苗的定价提供重要基准。”他补充说，同一款疫苗的生产商很可能倾向全球统一价格。</p></div><div class="GridItemConstrainedMedium-sc-12lwanc-2 fVauYi"><p class="Paragraph-k859h4-0 bWtIRA">路透社报道称，辉瑞和莫德纳等都曾表示，会从疫苗中获利。</p></div><div class="GridItemConstrainedMedium-sc-12lwanc-2 fVauYi"><p class="Paragraph-k859h4-0 bWtIRA">英国牛津大学流行病学教授陈铮鸣此前对BBC中文表示，“公司研发（疫苗）成功了，会带来利益，这个也合理，因为它在前期也投入大量的资源和成本。”</p></div><div class="GridItemConstrainedMedium-sc-12lwanc-2 fVauYi"><p class="Paragraph-k859h4-0 bWtIRA">另一点值得注意的是，牛津大学和阿斯利康联合开发的疫苗尽管每剂成本价约为4美元，远低于辉瑞和BioNTech的报价，但政府投资在很大程度上抵消了研发成本，并承担了疫苗失败的风险。</p></div><div class="GridItemConstrainedLargeNoMargin-sc-12lwanc-5 Wrapper-sc-7tc6v2-0 cDqnzl"><div class="Figure-sc-6a3dhy-0 gJUCFc"><div class="StyledVideoContainer-sc-13p1a4d-0 bpuDKK"><iframe src="https://bbc.com/ws/av-embeds/cps/zhongwen/simp/world-54277046/p08mc089/zh-hans" title="多媒体播放器" allow="autoplay; fullscreen" scrolling="no" allowfullscreen="" class="StyledIframe-fuo2ed-1 jOjdak"></iframe><noscript><div class="StyledWrapper-sc-1pnftlt-0 jywlaE"><img srcSet="https://ichef.bbci.co.uk/images/ic/1024x576/p08mc10t.jpg 240w, https://ichef.bbci.co.uk/images/ic/1024x576/p08mc10t.jpg 320w, https://ichef.bbci.co.uk/images/ic/1024x576/p08mc10t.jpg 480w, https://ichef.bbci.co.uk/images/ic/1024x576/p08mc10t.jpg 624w, https://ichef.bbci.co.uk/images/ic/1024x576/p08mc10t.jpg 800w" alt="" src="https://images.weserv.nl/?url=ichef.bbci.co.uk/images/ic/1024x576/p08mc10t.jpg" aria-hidden="true" class="StyledImg-sc-7vx2mr-0 hIxkbt"/><div class="MessageWrapper-sc-1pnftlt-1 hQgJGW"><strong class="StyledMessage-sc-1pnftlt-2 efsyEb">你的器材不支持播放多媒体材料</strong></div></div></noscript></div><p>第一支新冠疫苗何时上市？</p></div></div></main>
